Silent Epidemic: Navigating Non-Alcoholic Fatty Liver Disease (NAFLD) & NASH in India

Silent Epidemic: Navigating Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) & Steatohepatitis (MASH) in India

In India, a hidden health crisis is quietly taking root: fatty liver disease, now primarily known as Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). This condition, previously referred to as Non-Alcoholic Fatty Liver Disease (NAFLD), affects a significant portion of our population, often without immediate symptoms. When MASLD progresses to Metabolic Dysfunction-Associated Steatohepatitis (MASH), formerly NASH, it can lead to severe liver damage, including cirrhosis and liver cancer. Understanding this silent threat and its management is crucial for safeguarding liver health in our community.

Decoding MASLD & MASH: The Evolving Understanding of Fatty Liver Disease

Fatty liver disease occurs when excessive fat accumulates in the liver cells. For decades, if this wasn't due to heavy alcohol consumption, it was termed NAFLD. However, medical understanding has evolved, leading to a more precise classification:

• Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): This term has largely replaced NAFLD. MASLD describes a fatty liver associated with metabolic risk factors such as obesity, type 2 diabetes, insulin resistance, high cholesterol, and high triglycerides. It highlights the strong link between lifestyle-related metabolic issues and liver fat accumulation, making it a more accurate descriptor for the vast majority of cases.
• Metabolic Dysfunction-Associated Steatohepatitis (MASH): This term replaces NASH. MASH is a more aggressive form of MASLD where, in addition to fat, there is significant inflammation and liver cell damage. If left untreated, MASH can lead to fibrosis (scarring), cirrhosis (severe scarring and liver dysfunction), and even hepatocellular carcinoma (liver cancer).

This terminology shift emphasizes that the disease is intrinsically linked to metabolic dysfunction, regardless of alcohol intake. It helps better identify at-risk individuals and guides more targeted management strategies.

The Silent Progression: Risk Factors, Symptoms, and What Happens to Your Liver

MASLD and MASH are often called 'silent' diseases because they typically present with no symptoms in their early stages. This makes early detection challenging but vital.

Key Risk Factors in the Indian Context:

The prevalence of MASLD/MASH is particularly high in India due to:

• Obesity and Central Obesity: A rising concern, particularly abdominal fat, which is strongly linked to insulin resistance.
• Type 2 Diabetes: A major driver, with a high percentage of diabetics also having MASLD.
• Insulin Resistance: The body's cells don't respond effectively to insulin, leading to higher blood sugar and fat accumulation in the liver.
• Dyslipidemia: Abnormal levels of cholesterol and triglycerides.
• Metabolic Syndrome: A cluster of conditions including high blood pressure, high blood sugar, excess body fat around the waist, and abnormal cholesterol levels.
• Genetic Predisposition: Certain genetic factors may increase susceptibility in the Indian population.

Symptoms to Watch For:

While often asymptomatic, some individuals may experience:

• Persistent fatigue or unexplained tiredness.
• Dull ache or discomfort in the upper right abdomen.
• Unexplained weight loss (in advanced stages).
• Weakness.
• Signs of advanced liver disease (cirrhosis), such as jaundice (yellow skin/eyes), swelling in the legs (edema), fluid accumulation in the abdomen (ascites), easy bruising, or confusion.

If you experience any of these symptoms, especially if you have known risk factors, it is crucial to consult a doctor.

The Progression of Liver Damage:

MASLD can progress through several stages:

1. Simple Steatosis (MASLD): Fat accumulates in the liver without significant inflammation or damage.
2. Steatohepatitis (MASH): Inflammation and liver cell damage occur alongside fat accumulation.
3. Fibrosis: Persistent inflammation leads to scarring of the liver tissue.
4. Cirrhosis: Severe and widespread scarring, impairing liver function significantly. This is irreversible and can lead to liver failure.
5. Hepatocellular Carcinoma (HCC): Liver cancer, which is a severe complication of cirrhosis.

Diagnosing Fatty Liver: From Screening to Advanced Evaluation

Early diagnosis is key to preventing the progression of MASLD to MASH and subsequent severe liver damage.

Initial Screening and Suspicion:

• Routine Blood Tests: Elevated liver enzymes (ALT, AST) found during a routine health check-up can indicate liver inflammation.
• Ultrasound: Often the first imaging test, it can detect fat in the liver but cannot differentiate between simple MASLD and MASH or assess fibrosis severity.

Advanced Diagnostic Tools:

To assess the severity of liver damage and rule out other causes, your doctor may recommend:

• FibroScan (Transient Elastography): A non-invasive test that uses ultrasound waves to measure liver stiffness, which correlates with the degree of fibrosis (scarring) and fat content (steatosis).
• MRI Elastography: A more advanced imaging technique that provides detailed assessment of liver stiffness and fat content.
• Liver Biopsy: While less frequently performed now with the advent of non-invasive tests, a liver biopsy remains the gold standard for definitively diagnosing MASH and staging the severity of inflammation and fibrosis. It involves taking a small sample of liver tissue for microscopic examination.
• Blood Biomarker Panels: Specific blood tests (e.g., FIB-4, NAFLD Fibrosis Score) can help estimate the risk of advanced fibrosis.

Comprehensive Management: Lifestyle, Medications, and Advanced Interventions

The cornerstone of MASLD and MASH management is lifestyle modification. While there are no specific medications universally approved for MASH, treatment focuses on managing underlying conditions and, in advanced cases, surgical interventions.

Lifestyle Modifications (The Primary Treatment):

• Weight Loss: Even a modest weight loss (5-10% of body weight) can significantly reduce liver fat, inflammation, and fibrosis.
• Balanced Diet: Adopt a healthy eating pattern. Focus on whole foods, fruits, vegetables, lean proteins, and healthy fats. Limit processed foods, sugary drinks, refined carbohydrates, and unhealthy saturated and trans fats. The Mediterranean diet is often recommended.
• Regular Physical Activity: Aim for at least 150 minutes of moderate-intensity aerobic exercise per week.
• Manage Co-morbidities: Strictly control blood sugar in diabetes, lower cholesterol and triglycerides, and manage high blood pressure.
• Avoid Alcohol: Even though it's non-alcoholic fatty liver disease, avoiding alcohol reduces additional stress on the liver.

Pharmacological Management:

While no drug is universally approved specifically for MASH, your doctor may prescribe medications to manage associated conditions:

• Diabetes Medications: Certain drugs for type 2 diabetes, such as GLP-1 receptor agonists (e.g., liraglutide, semaglutide) and SGLT2 inhibitors (e.g., empagliflozin, canagliflozin), have shown promise in improving liver histology in MASH patients.
• Lipid-Lowering Agents: Statins to manage high cholesterol.
• Vitamin E: May be considered in non-diabetic MASH patients without cirrhosis, but its use requires careful consideration.

Several new drugs targeting specific pathways of liver inflammation and fibrosis are currently in advanced clinical trials and show promising results.

Advanced Interventions:

• Bariatric Surgery: For individuals with severe obesity (BMI >35-40 kg/m²) and MASLD/MASH, bariatric surgery can lead to significant weight loss and often results in the resolution of MASLD/MASH or improvement in liver fibrosis.
• Liver Transplantation: In cases where MASH progresses to end-stage cirrhosis and liver failure, a liver transplant may be the only life-saving option. The Surgical Gastroenterology & Liver Transplant department at Iswarya Hospital offers advanced care for such complex conditions, providing comprehensive evaluation and highly specialized transplant services.

Empowering Your Health: When to Seek Help and Practical Tips

Proactive steps can make a significant difference in preventing or managing MASLD/MASH.

When to See a Doctor:

You should consider seeing a doctor if:

• You have known risk factors such as obesity, diabetes, or metabolic syndrome.
• You experience persistent fatigue, unexplained abdominal discomfort, or any symptoms suggestive of liver problems.
• Routine blood tests show elevated liver enzymes.
• You have a family history of liver disease.

Early consultation can lead to timely diagnosis and intervention, preventing irreversible liver damage.

Practical Tips for a Healthy Liver:

1. Prioritize a Balanced Diet: Emphasize fresh produce, whole grains, and lean proteins. Reduce intake of sugary drinks, fast food, and processed snacks.
2. Maintain a Healthy Weight: Even small amounts of weight loss can improve liver health.
3. Stay Active: Incorporate regular physical activity into your daily routine.
4. Manage Chronic Conditions: Work closely with your doctor to control diabetes, high blood pressure, and high cholesterol.
5. Limit Unnecessary Medications: Always consult your doctor before taking new medications or supplements, as some can impact liver function.
6. Regular Health Check-ups: Especially if you are at risk, routine screening can help detect MASLD/MASH early.

Conclusion

MASLD and MASH represent a significant and growing public health challenge in India, often progressing silently to severe liver disease. However, with increased awareness, early diagnosis, and proactive management centered on lifestyle changes, the progression of this disease can be halted or even reversed. Iswarya Hospital is committed to providing comprehensive, state-of-the-art care for liver conditions, from early detection and management to advanced surgical gastroenterology and liver transplantation, ensuring the best possible outcomes for our patients. Prioritize your liver health today; it's an investment in your overall well-being.

Please note: This information is for general educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional for diagnosis and treatment of any medical condition.